How to Get Wegovy for Weight Loss

Summary: You qualify for Wegovy if your BMI is 30 or higher, or 27 or higher with one weight-related condition; the fastest paths are your PCP plus a prior authorization, NovoCare self-pay at $499 per month, or a telehealth visit that prescribes the brand pen.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: you qualify for a Wegovy prescription if your BMI is 30 or higher, or if your BMI is 27 or higher with at least one weight-related condition such as hypertension, type 2 diabetes, sleep apnea, dyslipidemia, or cardiovascular disease ^[1]. From there you have three real paths to the drug. Walk into your primary care doctor or an endocrinologist with documentation. Use NovoCare self-pay at roughly $499 a month with no insurance involved. Or do a telehealth visit through Ro, Hims, LifeMD, or a similar service that can write the prescription and route it to a pharmacy.

What follows is the actual mechanics. Who qualifies. What to bring. What it costs. What to do when insurance denies it and how to switch tracks fast.

Do you qualify for Wegovy?

The FDA label is specific. Wegovy is approved for chronic weight management in adults with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) when accompanied by at least one weight-related comorbid condition ^[1]. It is also approved for adolescents aged 12 and older with a BMI at the 95th percentile or above for their age and sex, and to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.

The qualifying comorbidities most prescribers and payers accept:

• Hypertension
• Type 2 diabetes
• Dyslipidemia (high cholesterol or triglycerides)
• Obstructive sleep apnea
• Cardiovascular disease
• Polycystic ovary syndrome (PCOS)
• Metabolic dysfunction-associated steatohepatitis (MASH)
• Osteoarthritis tied to weight

You do not qualify if you have a personal or family history of medullary thyroid carcinoma, or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Both are absolute contraindications on the label ^[1]. Pregnancy is also a contraindication; Wegovy is not used during pregnancy or while breastfeeding.

What to bring to the appointment

Doctors who prescribe Wegovy regularly want the same three things. Bring them and the visit gets faster.

1. BMI documentation. Your current height, weight, and BMI. If your last clinic visit was recent and they have the weight on file, that counts. If not, weigh yourself at home that morning.
2. At least one comorbidity confirmed in your chart. If your BMI is between 27 and 30 you need a documented qualifying condition. A blood pressure reading above 130/80 in your records, an HbA1c on file, a lipid panel, or a sleep apnea diagnosis is enough. If you have not been tested for the relevant conditions, ask for the labs at that visit. Some payers reject prior authorizations that cite a condition without a chart date.
3. A record of prior weight loss attempts. Most commercial insurers require evidence of a structured weight loss attempt of at least three to six months that did not produce sustained results. A note from a registered dietitian, a documented enrollment in a program like Weight Watchers or Noom, gym membership records, or a clinic-supervised diet logged in the chart all qualify. If none of those exist on paper, ask your doctor to document your history verbally and put it in the visit note. That is enough for many plans.

Bring your insurance card. Bring a list of current medications. If you have tried any other weight loss drug (phentermine, contrave, orlistat, liraglutide), bring the names and dates.

Route 1: Your primary care doctor or endocrinologist

The most boring path is usually the cheapest if you have insurance. PCPs and endocrinologists can prescribe Wegovy directly. You book a visit, walk through the eligibility checklist, and they send the prescription to your pharmacy.

The catch is the prior authorization. Most commercial plans require one for Wegovy. Some require step therapy, meaning you must have tried and failed an older weight loss medication first. Your prescriber's office submits the form. Approval typically takes one to fourteen days. If it goes through, the copay can be as low as $25 a month with Novo Nordisk's commercial savings card layered on top ^[2].

If your plan does not cover obesity medications at all, the prior auth will be denied not because you do not qualify but because the benefit category is excluded. Medicare Part D does not cover anti-obesity medications under federal law, with one exception: as of March 2024, Wegovy is covered under Part D for adults with established cardiovascular disease and either obesity or overweight, using the cardiovascular indication rather than the weight-loss indication. If you have Medicare and qualify on the cardiovascular grounds, that is your route in.

Route 2: NovoCare self-pay at $499 per month

Novo Nordisk runs a direct-to-patient cash channel called NovoCare Pharmacy. As of 2026, the self-pay price for the full Wegovy pen lineup through NovoCare is $499 per month for all maintenance doses (1.7 mg and 2.4 mg), with a starter pack arrangement for the lower titration doses that can run as low as $199 per month for the first two fills of the 0.25 mg and 0.5 mg pens through introductory offers ^[2]. The exact price varies by promotion and dose, but $499 is the steady-state cash figure for the maintenance pen most people are working toward.

You still need a prescription. NovoCare does not write one for you. The flow is: get the script from any prescriber, route it to NovoCare Pharmacy, pay cash, and they ship the pens to your door. No insurance interaction. No prior auth. The drug arrives in roughly a week.

This is the fastest path for two groups: people whose insurance excludes anti-obesity drugs, and people who do not want to spend a month on the prior authorization back-and-forth.

Route 3: Telehealth (Ro, Hims, LifeMD, Sesame, PlushCare)

Telehealth services run virtual visits with licensed clinicians who can prescribe Wegovy. The major players in 2026 are Ro Body, Hims (and the women's brand Hers), LifeMD, Noom Med, PlushCare, Sesame, and WeightWatchers Clinic. Walgreens Weight Management also runs a virtual program where the visit fee is $49 and Wegovy pricing starts at $199 per month for the introductory injectable offer ^[4].

The visit is asynchronous or video, usually 15 to 30 minutes, and the eligibility check is the same one your PCP would run. BMI documented, comorbidity (if needed) confirmed, contraindications ruled out. If you qualify, the prescription is sent to NovoCare Pharmacy or to a local pharmacy of your choice. You pay the cash price for the medication separately from the visit fee.

Telehealth makes sense if you do not have a PCP, your PCP refuses to prescribe GLP-1s, or you want the convenience of the entire process happening from a phone. It does not produce a cheaper drug; the molecule still comes from Novo Nordisk at the same wholesale price. What you are paying for is the visit and the routing.

What Wegovy actually does for weight loss

The clinical data is the reason this conversation is happening at all. In the STEP 1 trial, adults with a BMI of 30 or greater (or 27 or greater with at least one weight-related comorbidity) who received once-weekly semaglutide 2.4 mg lost an average of 14.9% of their body weight at 68 weeks, compared with 2.4% in the placebo group, with both arms receiving lifestyle intervention ^[3]. About one in three participants on semaglutide lost 20% or more of their starting body weight.

The dose schedule is built around tolerance. You start at 0.25 mg weekly for the first four weeks. Every four weeks the dose steps up: 0.5 mg, 1 mg, 1.7 mg, and then the maintenance dose of 2.4 mg. The titration exists because the gastrointestinal side effects (nausea, vomiting, constipation, diarrhea) are dose-dependent and most people tolerate the drug best if their gut has time to adapt at each step.

The pill version of Wegovy, approved in 2025, contains oral semaglutide and works through the same mechanism. Tablet doses are 1.5 mg, 4 mg, 9 mg, and 25 mg, taken once daily on an empty stomach with no more than 4 oz of water and a 30-minute wait before eating. The pill version is approved for adults only and not for the MASH indication. Weight loss results are broadly comparable between the pen and the pill at maintenance doses.

Navigating prior authorization

Almost every commercial plan that covers Wegovy requires a prior authorization. The form your prescriber submits asks for:

• Your current BMI, with the date measured
• Qualifying comorbidities with documentation dates
• Evidence of a prior weight loss attempt (often 3 to 6 months)
• A statement that you will continue lifestyle modification alongside the drug
• Confirmation that you have no contraindications

If the prior auth is denied, read the denial letter before doing anything else. The denial reason tells you what to do next.

• "BMI does not meet criteria." Usually means the BMI on file is below the threshold the plan uses. Re-weigh, re-document, re-submit.
• "No documented comorbidity." The chart needs an explicit ICD code for the qualifying condition, not just a passing mention. Have your prescriber add a diagnosis code and resubmit.
• "Step therapy required." The plan wants you to try a cheaper drug first, usually phentermine, contrave, or liraglutide (Saxenda). You either complete the step or your prescriber appeals on medical necessity grounds (e.g., a documented contraindication to the step drug).
• "Not a covered benefit." Your plan does not cover anti-obesity medications at all. No amount of appeal will reverse this; switch to NovoCare self-pay or change plans at open enrollment.

A denial that is not a benefit exclusion can almost always be appealed. The appeal goes back through your prescriber. Add any missing documentation, include a letter of medical necessity citing the FDA label and the STEP 1 outcomes, and resubmit. First-level appeals on Wegovy denials have a meaningful success rate when the underlying clinical case is strong.

If denied: switch to Zepbound

If insurance refuses Wegovy and self-pay is out of reach, ask your prescriber about Zepbound. Zepbound is Eli Lilly's brand name for tirzepatide, approved for chronic weight management in adults with the same BMI criteria as Wegovy. In head-to-head trial data and a direct comparison study, tirzepatide produced larger average weight loss than semaglutide at maximum doses. Some plans cover Zepbound but not Wegovy, or vice versa, because the formulary committees made different bets. A clean switch to Zepbound is often the fastest workaround for a Wegovy denial.

Lilly runs an equivalent direct-to-patient channel called LillyDirect, where Zepbound single-dose vials are sold at $349 to $499 per month for cash-pay patients depending on dose, and Zepbound pens are also available. If both manufacturer cash channels are still too expensive, the next step is to ask your prescriber about generic or older weight loss medications (phentermine, contrave, orlistat) which are dramatically cheaper, though their effect sizes are smaller.

State of access in 2026

A few practical notes specific to the current market.

• Wegovy supply is normalized. The 2023 to 2024 shortage that put semaglutide on the FDA shortage list has been resolved. All doses are generally available through retail pharmacies and NovoCare.
• The Wegovy pill was approved in 2025 and is widely stocked. Some people prefer it for needle aversion; most insurance plans cover it under the same prior auth rules as the pen.
• Compounded semaglutide is no longer in a protected gray zone. The FDA's removal of semaglutide from the shortage list ended the legal carve-out that allowed 503A pharmacies to mass-produce it. Compounded semaglutide is still available in narrow personalized-medicine cases, but most large telehealth compounders have shifted to other peptides or wound down.
• The Wegovy.com site has a built-in eligibility checker and a coverage lookup tool that pulls your plan's formulary in real time. Worth ten minutes before the visit ^[4].
• Buying Wegovy without a prescription is not legal in the US. Sites that advertise Wegovy over the counter, sublingual Wegovy, or Wegovy at-cost from overseas suppliers are either selling something that is not Wegovy or are selling Wegovy in a way that violates federal law. The UK has private clinic access (Boots, Lloyds, Numan) where Wegovy is prescription-only and not available over the counter; the US has no over-the-counter equivalent.

A simple decision tree

If you want the cheapest possible path and you have insurance that covers anti-obesity drugs: go to your PCP, request Wegovy, complete the prior auth, layer the Novo Nordisk commercial savings card on top. Total cost: $25 a month or less.

If you want the fastest path and your insurance does not cover it (or you do not want to deal with it): get a prescription from a telehealth provider, route it to NovoCare Pharmacy, pay $499 a month (or the introductory $199 for the starter doses). Total time to first dose: about a week.

If you have Medicare and established cardiovascular disease: ask your prescriber to file the prescription using the cardiovascular indication; Part D will cover it.

If you get denied and self-pay is out of reach: ask about Zepbound, then about generic anti-obesity drugs.

Common questions about getting Wegovy

How can I get a prescription for Wegovy?

Through a primary care doctor, endocrinologist, obesity medicine specialist, or a telehealth service (Ro, Hims, LifeMD, Walgreens Weight Management, Sesame, WeightWatchers Clinic). Bring documented BMI, any qualifying comorbidity, and a history of prior weight loss attempts.

Can I get Wegovy without insurance?

Yes. NovoCare Pharmacy sells Wegovy direct to cash-pay patients at about $499 per month for maintenance doses, with introductory pricing around $199 per month for the starter 0.25 mg and 0.5 mg doses. You still need a valid prescription from any licensed prescriber.

What is the best place to get Wegovy online?

For the brand-name drug at manufacturer-direct pricing, NovoCare Pharmacy is the most reliable. For the visit-plus-prescription bundle, Ro Body, LifeMD, Hims/Hers, and Walgreens Weight Management are the most established services in 2026.

How do I get a doctor to prescribe Wegovy?

Show up with current BMI, a documented qualifying condition (if your BMI is between 27 and 30), and notes on prior weight loss attempts. State clearly that you want to discuss Wegovy specifically. Most PCPs will prescribe if you meet the FDA criteria and have no contraindications.

Can I buy Wegovy online without a prescription?

No. Wegovy is prescription-only in the US, UK, and EU. Sites selling "over the counter Wegovy" or no-prescription semaglutide are either illegal, fraudulent, or selling compounded products that are not Wegovy. In the UK, private clinics like Boots, Lloyds, and Numan dispense Wegovy on a prescription written after an online assessment.

How can I get Ozempic for free?

You generally cannot. Ozempic is the type 2 diabetes brand of semaglutide and is not approved for weight loss alone. Novo Nordisk runs a Patient Assistance Program for low-income uninsured patients with diabetes that can provide Ozempic at no cost; eligibility is income-based.

What if my insurance denies Wegovy?

Read the denial letter to identify the reason. Have your prescriber appeal with additional documentation or a letter of medical necessity. If the denial is a benefit exclusion (no coverage for anti-obesity drugs), switch to NovoCare self-pay or ask about Zepbound, which some plans cover when Wegovy is not on formulary.

How long does it take to get Wegovy after the prescription is written?

Three to seven days for cash-pay through NovoCare or a retail pharmacy. One to four weeks if the prescription has to go through a prior authorization first.

Is the Wegovy pill easier to get than the pen?

Same prescription process, same prior auth, similar self-pay pricing. The pill is approved only for adults (the pen is approved from age 12). If you prefer to avoid injections and meet the criteria, ask your prescriber about the oral version.

How much weight will I actually lose on Wegovy?

In the STEP 1 trial the average weight loss at 68 weeks on the 2.4 mg maintenance dose was 14.9% of starting body weight, with about a third of participants losing 20% or more ^[3]. Real-world results vary by adherence, dose tolerance, and lifestyle changes.

What this page does not cover

Pricing, supply, and prior authorization rules shift quarterly. The specific dollar figures cited here are accurate for early 2026. Verify the current NovoCare cash price, your specific plan's formulary, and any active manufacturer savings offers before you budget. The eligibility criteria, contraindications, and clinical effect sizes are stable; those come from the FDA label and the trial record ^[1][3][5].